News und Analysen
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Regeneron Pharmaceuticals (NASDAQ: REGN) is a leader in the field of therapeutic proteins, with a history of more than 30 years of innovation and excellence. The biotech has partnered with Bayer to
3 Fantastic Stocks to Buy in a New Bull Market
A new bull market is here ... almost. Some maintain that the S&P 500 has already begun a new bull market. Others, though, argue that the index must reach an all-time high first. Either way, many
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Over the past few years, several hot investing trends swept through Wall Street. First, it was the metaverse, and now it's artificial intelligence; there will likely be some new big thing in a year
Why Shares in Philips Soared This Week
Shares in medical technology company Koninklijke Philips (NYSE: PHG), also called Royal Philips, rose by 9.5% in the week through Friday morning. The move comes as Philips unveiled a relationship
3 Reasons to Buy Medtronic Stock
Over the past few years, medical device companies have struggled as the pandemic disrupted much of the industry, and economic problems contributed to lower sales and increasing expenses. Healthcare
If You Invested $25,000 in UnitedHealth Stock 10 Years Ago, This Is How Much You Would Have Today
UnitedHealth Group (NYSE: UNH) has been a top healthcare stock to own for years. Today, it's among the largest healthcare companies in the world, worth $475 billion. Although it's a health insurer
2 Excellent Stocks to Buy and Hold Forever
Being a buy-and-hold investor has advantages. For instance, it can be less stressful than day trading, and the combination of time and compounding is a powerful wealth generator. However, with
1 High-Yield Dividend Stock That Looks Like a Screaming Buy
Pharma giant AbbVie (NYSE: ABBV) performed poorly in the first part of the year, especially after it reported its first-quarter results. This was its first quarterly update following the loss of
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled
Could Amgen Stock Help You Become a Millionaire?
Healthcare company Amgen (NASDAQ: AMGN) has been a reliable investment to own over what has been a turbulent year for the broader market. Its stock price is up 6.6% in that time, outpacing the 3.2%
Should You Buy This Blue Chip Dividend Stock?
Because investing is future-oriented, it is important that investors purchase businesses with ample growth potential in the years ahead. The best way to do this is to only consider investing in
Why Shares of SomaLogic Are Up Tuesday
Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock
Here's Why Pfizer's High-Yield Dividend Could Be Even Safer Than You Might Think
When a company's revenue and earnings plunge, it's understandable if investors begin to worry about its dividend. Pfizer (NYSE: PFE) reported a 53% year-over-year decline in revenue in its latest
Is GSK an Excellent Dividend Stock to Buy for Passive Income Investors?
Fool.com contributor Parkev Tatevosian evaluates GSK (NYSE: GSK) and its longer-term prospects to determine if it's a fantastic stock to buy for dividend stock investors.
*Stock prices used were
2 Blue Chip Dividend Stocks That Are Top Buys in August
If you are looking for reliable dividend stocks that can provide steady income and growth in any market condition, you might want to consider these two blue chip companies that have proven their
2 Top Biotech Stocks to Buy Right Now
Income investing can be a great strategy for people looking to match their recurring bills with recurring dividend income. The trick is diversifying across top businesses in numerous industries to
2 High-Yield Dividend Stocks That Could Be Incredible Bargains
High-yield dividend stocks often deliver better-than-average returns for investors over the long term, thanks to the power of compounding. Not all high-yield dividend stocks are table-pounding buys
3 Unstoppable Dividend Stocks to Buy Right Now
Income investors won't be happy with dividends that aren't sustainable. Instead, they want to own dividend stocks that they can depend on.
Three Motley Fool contributors identified stocks that
Why Shares of Sage Therapeutics Slumped This Week
Shares of Sage Therapeutics (NASDAQ: SAGE) were down by more than 40% for the week at 11 a.m. on Friday, according to data provided by S&P Global Market Intelligence. The pharmaceutical company's
Does Pfizer Stock Belong in a Dividend Portfolio?
Investing becomes an easier process the moment that you shift from a trading mindset to an ownership approach. That transformation begins when you realize that behind every stock ticker, there's a
Should Value Investors Buy This Healthcare Stock?
Value investing is a rather popular investing strategy. Seeing as almost everyone enjoys buying great products at discounted prices, it isn't surprising that we would also like to get good deals on
Is Abbott Laboratories Stock a Buy Now?
Abbott Laboratories (NYSE: ABT) posted its latest earnings numbers last month, and there's reason to be optimistic about the business. Although a drop in COVID testing means sales are down overall
Will UnitedHealth Group Be a Trillion-Dollar Stock by 2030?
In the realm of investing, market capitalization is a good but not perfect way to gauge the success of a business. Sure, sometimes companies are overvalued. But a company's market value can at least
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Biogen (NASDAQ: BIIB) is an intriguing stock right now. Its business has struggled to generate growth in recent years, but some recent catalysts could turn things around. For starters, the company's
My Oh My, Merck Stock Is a No-Brainer Income Stock to Buy
Investing for income may never be the most exciting investment strategy in the world. But as long as a company doesn't cut or suspend its dividend, it can be a profitable approach -- and some